메뉴 건너뛰기




Volumn 7, Issue 1, 2008, Pages 6-18

Liver tolerance and the manipulation of immune outcomes

Author keywords

Hepatitis C virus; Liver; T cells; Tolerance; Transplantation

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; CORTICOSTEROID; CPG 10101; CYCLOSPORIN A; DENDRITIC CELL VACCINE; FINGOLIMOD; HEPATITIS C VACCINE; IC 41; IMMUNOSUPPRESSIVE AGENT; ISATORIBINE; KRP 203; L SELECTIN; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROTEIN ANTIBODY; RECOMBINANT ALPHA INTERFERON; RIBAVIRIN; SPHINGOSINE DERIVATIVE; TACROLIMUS; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR AGONIST;

EID: 43449100364     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152808784165225     Document Type: Review
Times cited : (12)

References (120)
  • 99
    • 10744230053 scopus 로고    scopus 로고
    • Budde, K.; R, L.S.; Nashan, B.; Brunkhorst, R.; P, W.L.; Mayer, T.; Brookman, L.; Nedelman, J.; Skerjanec, A.; Bohler, T.; Neumayer, H.H. Am. J. Transplant., 2003, 3, 846.
    • Budde, K.; R, L.S.; Nashan, B.; Brunkhorst, R.; P, W.L.; Mayer, T.; Brookman, L.; Nedelman, J.; Skerjanec, A.; Bohler, T.; Neumayer, H.H. Am. J. Transplant., 2003, 3, 846.
  • 112
    • 43449115879 scopus 로고    scopus 로고
    • Anadys Pharmaceuticals, 2007, Development Discontinued for AN A975, an Early Stage Compound for Treatment of Hepatitis C Virus Infection. http://ir.anadyspharma.com/phoenix.zhtml?c=148908&p= irol-newsArticle&ID=1032389&highlight=, 2007. Accessed Dec 1, 2007.
    • Anadys Pharmaceuticals, 2007, Development Discontinued for AN A975, an Early Stage Compound for Treatment of Hepatitis C Virus Infection. http://ir.anadyspharma.com/phoenix.zhtml?c=148908&p= irol-newsArticle&ID=1032389&highlight=, 2007. Accessed Dec 1, 2007.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.